EKF Diagnostics Holdings plc (EKDHF)
OTCMKTS · Delayed Price · Currency is USD
0.3900
0.00 (0.00%)
At close: Aug 12, 2025
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of $164.46 million as of August 26, 2025. Its market cap has decreased by -0.82% in one year.
Market Cap
164.46M
Enterprise Value
149.83M
Revenue
62.84M
Ranking
n/a
PE Ratio
21.05
Stock Price
$0.39
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 3.76M to 164.46M, an increase of 4,276.49%. That is a compound annual growth rate of 18.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 172.57M | 12.52% |
| Dec 31, 2024 | 153.37M | -16.15% |
| Dec 29, 2023 | 182.92M | -33.26% |
| Dec 30, 2022 | 274.07M | -41.83% |
| Dec 31, 2021 | 471.14M | 5.71% |
| Dec 31, 2020 | 445.71M | 116.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |